NextCell Pharma AB — Investor Relations & Filings
NextCell Pharma AB is a biopharmaceutical company developing advanced cell therapies for autoimmune diseases. Its lead drug candidate, ProTrans, is a novel stromal cell therapy in Phase II clinical trials for the treatment of type 1 diabetes. ProTrans is based on a patented technology platform for selecting and manufacturing potent cell products. In addition to its therapeutic development, NextCell operates Cellaviva, a private stem cell bank that provides services for the collection and storage of umbilical cord blood and tissue stem cells for future medical use. The company leverages its expertise in advanced cell handling, processing, and logistics for its clinical projects and collaborative services.
Recent filings
No filings indexed yet
We are still gathering filings for NextCell Pharma AB. .
No filings match the current filters
Try clearing the filters, or .
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Astellas Pharma Inc.
A global pharmaceutical company turning innovative science …
|
4503 | JP | Manufacturing |
|
ASTONEA LABS LIMITED
A CDMO specializing in pharmaceutical and cosmeceutical R&D…
|
544409 | IN | Manufacturing |
|
Astra Industrial Group
Diversified producer of pharmaceuticals, specialty chemical…
|
1212 | SA | Manufacturing |
|
AstraZeneca Pharma India Ltd.
Science-led biopharmaceutical organization focused on oncol…
|
ASTRAZEN | IN | Manufacturing |
|
AstraZeneca PLC
A global, science-led biopharmaceutical company developing …
|
AZN | GB | Manufacturing |
|
Astria Therapeutics, Inc.
Clinical-stage biopharma developing therapies for allergic …
|
ATXS | US | Manufacturing |
|
Asymchem Laboratories (Tianjin) Co., Ltd.
A leading CDMO providing comprehensive, integrated pharmace…
|
6821 | HK | Manufacturing |
|
Asymchem Laboratories (Tianjin) Co., Ltd.
Global CDMO providing integrated CMC services across the dr…
|
002821 | CN | Manufacturing |
|
ATAI Life Sciences N.V.
Develops psychedelic-inspired therapies for mental health d…
|
ATAI | NL | Manufacturing |
|
Atea Pharmaceuticals, Inc.
Clinical-stage biopharma developing oral antiviral therapie…
|
AVIR | US | Manufacturing |
NextCell Pharma AB via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/8504/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=8504 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=8504 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=8504 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 8504}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for NextCell Pharma AB (id: 8504)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.